Global Diabetes Testing System Market Growth 2025-2031

The global Diabetes Testing System market size is predicted to grow from US$ 4097 million in 2025 to US$ 6960 million in 2031; it is expected to grow at a CAGR of 9.2% from 2025 to 2031.

Diabetes Testing Systems are the systems used at home or health care settings for monitoring the blood glucose levels in diabetic patients. Testing blood glucose level is the best way to understand diabetes and how different foods, medications, and other activities affect diabetes.

The market for diabetes testing systems has been witnessing significant growth in recent years due to the increasing prevalence of diabetes and the growing awareness about the importance of regular monitoring of blood glucose levels. According to the International Diabetes Federation, the number of people with diabetes is projected to reach 700 million by 2045.

The market is driven by factors such as the rising geriatric population, sedentary lifestyles, unhealthy dietary habits, and the increasing prevalence of obesity. Additionally, advancements in technology have led to the development of innovative glucose monitoring systems that offer better accuracy, convenience, and ease of use.

Key players in the global diabetes testing system market include Abbott Laboratories, Roche Diagnostics, Dexcom, Inc., Medtronic plc, Ascensia Diabetes Care Holdings AG, Johnson & Johnson, and Becton, Dickinson and Company, among others. These companies invest in research and development activities to introduce new and advanced diabetes testing systems in the market.

The market is segmented based on product type, which includes self-monitoring blood glucose systems, continuous glucose monitoring systems, and others. Geographically, North America holds a significant share in the market, followed by Europe and the Asia Pacific region.

The global diabetes testing system market is anticipated to witness continued growth in the coming years, driven by the increasing prevalence of diabetes and the continuous efforts of market players to develop and commercialize innovative testing systems.

LP Information, Inc. (LPI) ' newest research report, the “Diabetes Testing System Industry Forecast” looks at past sales and reviews total world Diabetes Testing System sales in 2024, providing a comprehensive analysis by region and market sector of projected Diabetes Testing System sales for 2025 through 2031. With Diabetes Testing System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetes Testing System industry.

This Insight Report provides a comprehensive analysis of the global Diabetes Testing System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diabetes Testing System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diabetes Testing System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetes Testing System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetes Testing System.

This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Testing System market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Self-Monitoring Diabetes Testing Systems

Continuous Diabetes Testing Systems

Others

Segmentation by Application:

Home Care

Hospitals

Clinics

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Roche Holding AG

Abbott Laboratories

Sanofi S.A.

ACON Laboratories

Nova Biomedical

Nipro Corporation

Braun Holding GmbH

DexCom

Medtronic Plc

ARKRAY

LifeScan

Ascensia Diabetes Care

Key Questions Addressed in this Report

What is the 10-year outlook for the global Diabetes Testing System market?

What factors are driving Diabetes Testing System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Diabetes Testing System market opportunities vary by end market size?

How does Diabetes Testing System break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.